Cover Image
市場調查報告書

Biosceptre International Limited:產品平台分析

Biosceptre International Limited - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 319967
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Biosceptre International Limited:產品平台分析 Biosceptre International Limited - Product Pipeline Review - 2014
出版日期: 2014年11月24日 內容資訊: 英文 21 Pages
簡介

Biosceptre International Limited 是開發及商品化癌症診斷及治療可用之抗體技術的生物科技企業。該公司正在開發用來發現、檢查癌症所用的影像技術。該公司的診斷設備不僅人類,甚至也可用來檢查哺乳類動物的各種癌組織及癌症上。

本報告提供Biosceptre International Limited 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Biosceptre International Limited的基本資料

  • Biosceptre International Limited概要
  • 主要資訊
  • 企業資料

Biosceptre International Limited :R&D概要

  • 主要的治療範圍

Biosceptre International Limited :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Biosceptre International Limited :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Biosceptre International Limited :藥物簡介

  • BIL-010t
  • Cell Therapy for Gastrointestinal Tumor
  • BIL-221s

Biosceptre International Limited :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Biosceptre International Limited :最近的開發平台趨勢

Biosceptre International Limited :總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC06521CDB

Summary

Global Markets Direct's, 'Biosceptre International Limited - Product Pipeline Review - 2014', provides an overview of the Biosceptre International Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Biosceptre International Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Biosceptre International Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Biosceptre International Limited's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Biosceptre International Limited's pipeline products

Reasons to buy

  • Evaluate Biosceptre International Limited's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Biosceptre International Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Biosceptre International Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Biosceptre International Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Biosceptre International Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Biosceptre International Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Biosceptre International Limited Snapshot
    • Biosceptre International Limited Overview
    • Key Information
    • Key Facts
  • Biosceptre International Limited - Research and Development Overview
    • Key Therapeutic Areas
  • Biosceptre International Limited - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Biosceptre International Limited - Pipeline Products Glance
    • Biosceptre International Limited - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Biosceptre International Limited - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Biosceptre International Limited - Drug Profiles
    • BIL-010t
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cell Therapy for Gastrointestinal Tumor
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BIL-221s
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Biosceptre International Limited - Pipeline Analysis
    • Biosceptre International Limited - Pipeline Products by Target
    • Biosceptre International Limited - Pipeline Products by Route of Administration
    • Biosceptre International Limited - Pipeline Products by Molecule Type
    • Biosceptre International Limited - Pipeline Products by Mechanism of Action
  • Biosceptre International Limited - Recent Pipeline Updates
  • Biosceptre International Limited - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Biosceptre International Limited, Key Information
  • Biosceptre International Limited, Key Facts
  • Biosceptre International Limited - Pipeline by Indication, 2014
  • Biosceptre International Limited - Pipeline by Stage of Development, 2014
  • Biosceptre International Limited - Monotherapy Products in Pipeline, 2014
  • Biosceptre International Limited - Phase I, 2014
  • Biosceptre International Limited - Preclinical, 2014
  • Biosceptre International Limited - Pipeline by Target, 2014
  • Biosceptre International Limited - Pipeline by Route of Administration, 2014
  • Biosceptre International Limited - Pipeline by Molecule Type, 2014
  • Biosceptre International Limited - Pipeline Products by Mechanism of Action, 2014
  • Biosceptre International Limited - Recent Pipeline Updates, 2014

List of Figures

  • Biosceptre International Limited - Pipeline by Top 10 Indication, 2014
  • Biosceptre International Limited - Pipeline by Stage of Development, 2014
  • Biosceptre International Limited - Monotherapy Products in Pipeline, 2014
  • Biosceptre International Limited - Pipeline by Top 10 Target, 2014
  • Biosceptre International Limited - Pipeline by Top 10 Route of Administration, 2014
  • Biosceptre International Limited - Pipeline by Top 10 Molecule Type, 2014
  • Biosceptre International Limited - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top